Results 41 to 50 of about 155,598 (315)

Exosomes in HBV infection

Clinica Chimica Acta, 2023
Exosomes have been identified as important mediators of intercellular communication in several physiological and pathological processes. Hepatitis B is caused by infection with the hepatitis B virus (HBV), which impairs hepatocytes, with chronic infection resulting in cirrhosis or liver cancer.
Ziyu, Liu, Yanan, Li, Yufeng, Wang, Xinquan, Bai, Ying, Zhang   +4 more
openaire   +2 more sources

Analysis of influencing factors on re-entry of HBV DNA reactive blood donors

Zhongguo shuxue zazhi, 2022
Objective To explore the factors affecting NAT reactive blood donors re-entry, so as to provide data support for formulation of scientific and reasonable strategy.
Mingjun CHEN, Yifang WANG, Lumin YAN, Yueguang WEI, Tiantian TU, Lei ZHAO, Yonglei LYU   +6 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Geographic and species association of hepatitis B virus genotypes in non-human primates [PDF]

, 2003
Infection with hepatitis B virus (HBV) has been detected in human populations throughout the world, as well as in a number of ape species (Pan troglodytes, Gorilla gorilla, gibbons [Nomascus and Hylobates species] and Pongo pygmaeus).
Holmes, E.C, MacDonald, D M, Holmes, E C, MacDonald, D.M, Starkman, S.E, Lewis, J.C.M, Lewis, J C M, Starkman, S E, Simmonds, P   +8 more
core   +1 more source

Natural Biomaterials for Osteochondral Repair: From Source to Strategy

Advanced Healthcare Materials, EarlyView.
Biological origin‐guided overview of natural biomaterials and therapeutic strategies for osteochondral tissue engineering. The circular diagram categorizes representative materials and strategies into plant/algae‐derived, microbial‐derived, animal‐derived, and human‐derived sources, centered on an osteochondral defect repair model.
Hengyu Liu, Hanyang Zhang, Wenbo Yang, Hao Chen, Jincheng Wang, Fei Chang   +5 more
wiley   +1 more source

Evaluación del desempeño de modelos hidrológicos GR4J, HBV y SOCONT para el pronóstico de caudales medios diarios en la cuenca del río Ramis, Perú [PDF]

Revista Ingeniería UC, 2020
Las inundaciones son fenómenos naturales que han ocurrido a lo largo de la historia. La frecuencia con la que se presentan ha inducido importantes pérdidas humanas, pérdidas en la agricultura, el sistema socioeconómico y daños a la infraestructura ...
Efrain Lujano, Jesús David Sosa, Rene Lujano, Apolinario Lujano   +3 more
doaj  

Native preparation of immobilized recombinant MBP-HBV-miniP-BAP protein.

, 2022
(A) Domain structure of the MBP-HBV-miniP-BAP protein. The protein is identical to MBP-HBV-miniP-H6 (S5 Fig) except that the C terminal His6 tag is replaced by a Biotin-Acceptor-Peptide (BAP; also known as Avi-tag); its central K residue can be ...
Katharina Dörnbrack (12213595), Michael Nassal (163597), Jürgen Beck (195467)   +2 more
core   +1 more source

TRMT6‐Mediated m1A Modification of CDK9 mRNA Is a Dual‐Pronged Pathogenic Driver for HBV‐Related Hepatocellular Carcinoma

Advanced Science, EarlyView.
TRMT6‐mediated m1A modification in CDK9 mRNA enhances its mRNA stability and translation efficiency, thereby increasing the protein levels of CDK9. Upregulated CDK9 promotes the progression of HCC by elevating the levels of oncogenic factors including p‐STAT3, MCL1, and BCL‐2. On the other hand, CDK9 phosphorylates TARDBP at Ser254 to activate HBV core
Rui Zhang, Dandan Zong, Rui Liu, Yubo Wang, Qingqing Gu, Yao Yao, Wenfang Zheng, Mengmeng Yuan, Simeng Wang, Rongrong Cui, Daxu Li, Siwen Dang, Peng Hou   +12 more
wiley   +1 more source

HBsAg loss in chronic hepatitis B patients with an HBsAg decline plateau can be enhanced by intermittent PEG-IFN treatment

Frontiers in Cellular and Infection Microbiology
BackgroundDuring interferon (IFN) treatment patients with chronic hepatitis B (CHB), HBsAg levels often declines to a plateau. This study investigated the HBsAg loss rate in patients receiving continuous IFN treatment after reaching a plateau compared ...
Weihua Cao, Weihua Cao, Si Xie, Hongxiao Hao, Hongxiao Hao, Wen Deng, Wen Deng, Lu Zhang, Lu Zhang, Yao Lu, Yao Lu, Ruyu Liu, Ruyu Liu, Shiyu Wang, Shiyu Wang, Xinxin Li, Xinxin Li, Ziyu Zhang, Ziyu Zhang, Xin Wei, Xin Wei, Zixuan Gao, Zixuan Gao, Linmei Yao, Linmei Yao, Shuojie Wang, Shuojie Wang, Yuanjiao Gao, Yuanjiao Gao, Yujie Wang, Yujie Wang, Mengjiao Xu, Mengjiao Xu, Leiping Hu, Leiping Hu, Yao Xie, Yao Xie, Yao Xie, Minghui Li, Minghui Li, Minghui Li   +40 more
doaj   +1 more source

Persistence of immunity 18–19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy

Human Vaccines & Immunotherapeutics, 2017
This study was aimed at assessing the anti-HBs persistence and immune memory 18–19 y after vaccination against hepatitis B in healthy individuals primed as infants or adolescents.
Luisa Romanò, Cristina Galli, Catia Tagliacarne, Maria Elena Tosti, Claudio Velati, Laura Fomiatti, Maria Chironna, Rosa Cristina Coppola, Mario Cuccia, Rossana Mangione, Fosca Marrone, Francesco Saverio Negrone, Antonino Parlato, Carla Maria Zotti, Alfonso Mele, Alessandro Remo Zanetti, the Study Group   +16 more
doaj   +1 more source